316 related articles for article (PubMed ID: 20107730)
1. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
Kuraishi N; Nagai Y; Hasegawa M; Ishikawa O
Acta Derm Venereol; 2010; 90(1):73-6. PubMed ID: 20107730
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
3. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
Kawakami T; Kawanabe T; Soma Y
Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
[No Abstract] [Full Text] [Related]
4. Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review.
Wahiduzzaman M; Pubalan M
Dermatol Online J; 2008 Dec; 14(12):14. PubMed ID: 19265627
[TBL] [Abstract][Full Text] [Related]
5. Oral lichenoid eruption associated with imatinib treatment.
Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
[No Abstract] [Full Text] [Related]
6. Oral lichenoid reaction to imatinib (STI 571, Gleevec).
Lim DS; Muir J
Dermatology; 2002; 205(2):169-71. PubMed ID: 12218235
[TBL] [Abstract][Full Text] [Related]
7. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia.
Machaczka M; Gossart M
Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191
[No Abstract] [Full Text] [Related]
8. Cutaneous Lichenoid dermatitis associated with imatinib mesylate.
Chan CY; Browning J; Smith-Zagone MJ; Martinelli PT; Hsu S
Dermatol Online J; 2007 May; 13(2):29. PubMed ID: 17498448
[No Abstract] [Full Text] [Related]
9. Hypertrophic lichenoid eruption due to furosemide.
Arias-Santiago S; Aneiros-Fernandez J; Aceituno-Madera P; Burkhardt-Perez P; Naranjo Sintes R
Acta Derm Venereol; 2010; 90(1):78-9. PubMed ID: 20107731
[No Abstract] [Full Text] [Related]
10. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism.
Vano-Galvan S; Fernandez-Guarino M; Henriquez-Santana A; De Las Heras E; Calbacho M; Jaen P
Eur J Dermatol; 2007; 17(6):538-9. PubMed ID: 17951138
[No Abstract] [Full Text] [Related]
11. Oral lichenoid eruption secondary to imatinib (Glivec).
Ena P; Chiarolini F; Siddi GM; Cossu A
J Dermatolog Treat; 2004 Jul; 15(4):253-5. PubMed ID: 15764042
[TBL] [Abstract][Full Text] [Related]
12. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
[No Abstract] [Full Text] [Related]
13. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
[TBL] [Abstract][Full Text] [Related]
14. Imatinib: a designer drug, another cutaneous complication.
Dickens E; Lewis F; Bienz N
Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
[TBL] [Abstract][Full Text] [Related]
15. Lichenoid drug eruption related to imatinib: report of a new case and review of the literature.
Sendagorta E; Herranz P; Feito M; Ramírez P; Feltes R; Floristán U; Mariño-Enriquez A; Casado M
Clin Exp Dermatol; 2009 Oct; 34(7):e315-6. PubMed ID: 19456782
[No Abstract] [Full Text] [Related]
16. Skin fragility and blistering with imatinib mesylate.
Verma SM; Murphy G
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):496-8. PubMed ID: 19925597
[No Abstract] [Full Text] [Related]
17. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
Pascual JC; Matarredona J; Miralles J; Conesa V; Borras-Blasco J
Int J Dermatol; 2006 Dec; 45(12):1471-3. PubMed ID: 17184272
[No Abstract] [Full Text] [Related]
18. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
Lau YM; Lam YK; Leung KH; Lin SY
Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
[No Abstract] [Full Text] [Related]
19. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
Breccia M; Carmosino I; Russo E; Morano SG; Latagliata R; Alimena G
Eur J Haematol; 2005 Feb; 74(2):121-3. PubMed ID: 15654902
[TBL] [Abstract][Full Text] [Related]
20. [Lichenoid cutaneous reaction to imatinib].
Roux C; Boisseau-Garsaud AM; Saint-Cyr I; Hélénon R; Quist D; Delaunay C
Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):571-3. PubMed ID: 15318140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
